Arialys Therapeutics

Home Team News Careers Contact

News

« Back to News

September 12, 2023

BioWorld | Newco News: Arialys has autoimmune solution to psychosis problem

Arialys Therapeutics Inc. launched this month with $58 million in seed funding, an experimental compound it is developing for autoimmune encephalitis and autoimmune psychosis, and high aspirations for its field. “Yes, I want to treat these patients, I want these patients to have a better life. But I also want drug discovery and development folks to think differently about discovering new drugs for the CNS,” Jay Lichter told BioWorld.

To read the full article, click here (subscription may be required).

Sign up for news updates

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Follow us

©2024 Arialys Therapeutics, 11099 North Torrey Pines Rd., Ste 290, La Jolla, CA 92037